Ogura, S., Yoshida, Y., Kurahashi, T., Egawa, M., Furuta, K., Kiso, S., . . . Takehara, T. (2018). Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma. Oncotarget.
Citação norma ChicagoOgura, Satoshi, et al. "Targeting the Mevalonate Pathway Is a Novel Therapeutic Approach to Inhibit Oncogenic FoxM1 Transcription Factor in Human Hepatocellular Carcinoma." Oncotarget 2018.
Citação norma MLAOgura, Satoshi, et al. "Targeting the Mevalonate Pathway Is a Novel Therapeutic Approach to Inhibit Oncogenic FoxM1 Transcription Factor in Human Hepatocellular Carcinoma." Oncotarget 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.